If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.